6XPP | pdb_00006xpp

Crystal structure of itaconate modified Mycobaterium tuberculosis isocitrate lyase


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.55 Å
  • R-Value Free: 
    0.179 (Depositor), 0.188 (DCC) 
  • R-Value Work: 
    0.158 (Depositor), 0.170 (DCC) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 6XPP

Ligand Structure Quality Assessment 


This is version 1.2 of the entry. See complete history

Literature

Itaconate is a covalent inhibitor of the Mycobacterium tuberculosis isocitrate lyase.

Kwai, B.X.C.Collins, A.J.Middleditch, M.J.Sperry, J.Bashiri, G.Leung, I.K.H.

(2021) RSC Med Chem 12: 57-61

  • DOI: https://doi.org/10.1039/d0md00301h
  • Primary Citation Related Structures: 
    6XPP

  • PubMed Abstract: 

    Itaconate is a mammalian antimicrobial metabolite that inhibits the isocitrate lyases (ICLs) of Mycobacterium tuberculosis . Herein, we report that ICLs form a covalent adduct with itaconate through their catalytic cysteine residue. These results reveal atomic details of itaconate inhibition and provide insights into the catalytic mechanism of ICLs.


  • Organizational Affiliation
    • School of Chemical Sciences, The University of Auckland Private Bag 92019, Victoria Street West Auckland 1142 New Zealand j.sperry@auckland.ac.nz i.leung@auckland.ac.nz.

Macromolecule Content 

  • Total Structure Weight: 189.25 kDa 
  • Atom Count: 15,067 
  • Modeled Residue Count: 1,702 
  • Deposited Residue Count: 1,712 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Isocitrate lyase
A, B, C, D
428Mycobacterium tuberculosis H37RvMutation(s): 0 
Gene Names: iclRv0467MTV038.11
EC: 4.1.3.1
UniProt
Find proteins for P9WKK7 (Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv))
Explore P9WKK7 
Go to UniProtKB:  P9WKK7
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP9WKK7
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 2 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
ITN
(Subject of Investigation/LOI)

Query on ITN



Download:Ideal Coordinates CCD File
E [auth A],
H [auth B],
K [auth C],
N [auth D]
2-methylidenebutanedioic acid
C5 H6 O4
LVHBHZANLOWSRM-UHFFFAOYSA-N
MG
(Subject of Investigation/LOI)

Query on MG



Download:Ideal Coordinates CCD File
F [auth A]
G [auth A]
I [auth B]
J [auth B]
L [auth C]
F [auth A],
G [auth A],
I [auth B],
J [auth B],
L [auth C],
M [auth C],
O [auth D],
P [auth D]
MAGNESIUM ION
Mg
JLVVSXFLKOJNIY-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.55 Å
  • R-Value Free:  0.179 (Depositor), 0.188 (DCC) 
  • R-Value Work:  0.158 (Depositor), 0.170 (DCC) 
Space Group: P 21 21 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 79.314α = 90
b = 133.171β = 90
c = 159.318γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
XDSdata reduction
Aimlessdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Other privateNew Zealand--
Health Research Council (HRC)New Zealand--

Revision History  (Full details and data files)

  • Version 1.0: 2020-10-21
    Type: Initial release
  • Version 1.1: 2021-06-09
    Changes: Database references
  • Version 1.2: 2023-10-18
    Changes: Data collection, Database references, Refinement description